slide-1


The Lancet Summit: COPD and Lung Cancer

July 28-29, 2017| Perth, Australia

This new Summit, organised by The Lancet Respiratory Medicine and The Lancet Oncology, will cover all of the main areas of debate for patients with COPD and lung cancer from prevention, diagnosis, treatment through to palliative care. It will also look at shared lessons from having a better understanding of the development and management of both diseases.

Abstracts are invited by April 17, 2017 for presentation as posters to supplement the invited lectures on the following topics:

  • Prevention of COPD and lung cancer
  • Screening for COPD and lung cancer
  • Genetic insights into disease development
  • Disease management and current interventions

  • COPD and lung cancer: latest insights into treatment paradigms
  • Infectious complications in patient management
  • Latest advances in surgery and radiation
  • Post treatment and end of life care

The conference will be of interest to clinicians, oncologists, researchers, nurses, policy makers, and public and global health advocates working in respiratory diseases and lung cancer.

Submit Abstract Register Now View Programme
Speakers include
  • Renee Bittoun, University of Sydney, Australia
  • Guy Brusselle, Ghent University Hospital, Belgium
  • Marcelo Cypel, University of Toronto, Canada
  • Mike Daube, Curtin University, Australia
  • Harry de Koning, Erasmus Medical Center, The Netherlands
  • Jon Emery, University of Melbourne, Australia
  • Allan Glanville, University of New South Wales and St Vincent's Hospital, Australia
  • Stephen Gordon, Malawi-Liverpool Wellcome Programme of Clinical Tropical Research, Malawi
  • Christine Jenkins, The George Institute for Global Health, Concord Hospital and University of Sydney, Australia
  • Stein Kaasa, Norwegian University of Science and Technology, Norway
  • Peter Licht, Odense University Hospital and University of Southern Denmark, Denmark
  • Barry Make, National Jewish Health, USA
  • Guy Marks, University of New South Wales, Australia
  • Paul Mitchell, Austin Health, Victoria, Australia
  • Annemie Schols, Maastricht University Medical Centre, The Netherlands
  • Suresh Senan, VU University Medical Center, The Netherlands
  • Malcolm Sim, Monash University, Australia
  • Peter D Sly, The University of Queensland, Australia
  • John Upham, The University of Queensland, Australia
  • Grant Waterer, University of Western Australia, Australia
  • Ian Yang, The Prince Charles Hospital and The University of Queensland, Australia
Conference Committee
  • A/Prof David Collingridge, Editor-in-Chief, The Lancet Oncology
  • Prof Jon Emery, General Practice and Primary Health Care Academic Centre, University of Melbourne, Melbourne, VIC, Australia
  • Dr Emma Grainger, Editor-in-Chief, The Lancet Respiratory Medicine
  • Prof Christine Jenkins, George Institute for Global Health, Concord Clinical School, University of Sydney, Sydney, NSW, Australia
  • A/Prof Paul Mitchell, Associate Professor, University of Melbourne, Australia

Supporting Publications
Join the Conversation
#lancetsummit

Organised by
 
  • Elsevier
  • Lancet Respiratory Medicine
  • Lancet Oncology
Supported by
 
  • Perth Convention Bureau
  • Tourism
Supporting Partners
 
  • Apsr
  • ETOP
  • Moga
  • Netherlands
  • Oman
  • Tsanz